LONDON (Alliance News) - The following is a summary of top news stories Tuesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>GlaxoSmithKline</strong> PLC said it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off i Read More
LONDON (Alliance News) - Pharmaceutical companies are leading UK stocks higher Tuesday, with the sector buoyed by merger and acquisition activity and speculation. With little in the way of economic data to provide focus, and in the absence of a further deterioration of the political situati Read More
LONDON (Alliance News) - UK shares have opened slightly higher Tuesday following gains on Wall Street over the long Easter weekend. <br /><br />Merger and acquisition activity and discussion surrounding UK pharmaceutical giants <strong>GlaxoSmithKline</strong> and <strong>AstraZeneca</strong> Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off its Oncology portfolio, acquire Novartis' global Vaccines business, and create a dually-offered Consumer Healthcare business. The tr Read More
LONDON (Alliance News) - UK stocks are set to open marginally higher Tuesday, as European markets play catch-up with Wall Street, which made gains over the long Easter weekend despite ongoing tensions in Ukraine. Spreadbetters are indicating that the FTSE 100 will open slightly higher Tuesd Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said a group of executives including Chief Executive Officer Andrew Witty acquired shares and American Depositary Shares under the company performance share plan at a price of 1581.50 pence per share and USD52.55 per ADS Wednesday.<br /><br Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off its Oncology portfolio, acquire Novartis' global Vaccines business, and create a dually-offered Consumer Healthcare business. The tr Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday that its Incruse Ellipta treatment had been granted marketing authorisation in Canada for the treatment of chronic obstructive pulmonary disease. Incruse Ellipta contains 62.5 micrograms of umeclidinium delivered by the Ellipta dry Read More
LONDON (Alliance News) - <strong>RSA Insurance Group</strong> Chief Executive Stephen Hester Thursday went a long way to meeting his asset disposal target, selling the insurer's Polish and Baltic operations as part of its efforts to shore up its balance sheet in the wake of big losses in Irela Read More
LONDON (Alliance News) - GlaxoSmithKline PLC confirmed that it was investigating allegations of misconduct in its Jordan and Lebanon operations in a statement Wednesday, the latest in a series of mounting investigations across its business. The pharmaceutical giant is currently investigatin Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />JEFFERIES CUTS WILLIAM HILL TO 'HOLD' ('BUY') <br />----------<br />GOLDMAN CUTS IMPERIAL TOBACCO TO 'BUY' ('CONVICTION BUY LI Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said it has received US approval for once-weekly type 2 diabetes treatment Tanzeum or albiglutide, with the company now anticipating the US launch of the treatment in the third-quarter of 2014. In a statement, the pharmaceutical giant sai Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares and American Depositary Shares under the 2009 deferred annual bonus plan at a price of 1581.50 pence per share and USD53.42 per ADS each following a dividend Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said Moncef Slaoui, a divisional chairman, and connected person K Slaoui, bought 5 American Depositary Shares under the GSK 401K plan at a price of USD51.76 per ADS. Glaxo shares were trading at USD51.89, up 0.2%, Monday. By Arvind B Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it was continuing to investigate allegations of bribery in its Polish operations and was co-operating fully with Poland's Central Anti-Corruption Office, after the BBC Panorama programme reported that eleven doctors and one of the comp Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it was continuing to investigate allegations of bribery in its Polish operations and was co-operating fully with Poland's Central Anti-Corruption Office, after the BBC Panorama programme reported that eleven doctors and one of the comp Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br />COMPANIES<br />----------<br /><strong>Aviva</strong> said it has agreed to sell its 47% stake in South Korean business Woori Aviva Life Insurance to NongHyup Financial Group, as the insurer co Read More
LONDON (Alliance News) - <strong>Aviva</strong> has Monday agreed to sell its 47% stake in its South Korean joint venture Woori Aviva Life Insurance to NongHyup Financial Group, as it continues to contract in the region and focus on markets where it can make the best returns on capital. <br /> Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning: ---------- FTSE 100 ---------- UBS REMOVED SCHRODERS FROM LEAST PREFERRED LIST ---------- UBS RAISES SCHRODERS PRICE TARGET TO 2700 (2650) PENCE - 'NEUTRAL' Read More
LONDON (Alliance News) - Glencore Xstrata said Monday it has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash. The deal is part of an agreement to w Read More